What is the oncological safety profile of MSC exosomes in patients with a history of...

The Sleeping Cells: Unravelling the Science of Late Breast Cancer Relapse and the Bone Marrow Sanctuary For many women diagnosed with breast cancer, undergoing successful primary treatment and receiving a "clean bill of health" brings immense relief. Yet, a clinical shadow remains: between 10% and 30% of survivors will experience a disease recurrence years, or even decades, after their primary tumour was successfully removed. For decades, this...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.